Alectinib
ATC L01ED03 · 10 markets · 15 records
US 2 records · 1 strengths
- 150 mgcapsuleALECENSA__no_trade__
GB 2 records · 1 strengths
- 150 mgcapsuleALECENSA
AU 2 records · 2 strengths
- 150 mgcapsuleALECENSA
Records without a stated strength · 1 ALECENSA
ES 2 records · 1 strengths
- 150 mgcapsuleALECENSA
CA 1 records · 1 strengths
- 150 mgcapsuleALECENSARO
CN 1 records · 1 strengths
- 150 mgcapsule安圣莎盐酸阿来替尼
TW 1 records · 1 strengths
- 150 mgcapsuleALECENSA安立適膠囊150毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 ALECENSA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ALECENSA
| Strength / form / release | US | GB | CA | AU | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 150 mg capsule | No trade name ALECENSA | ALECENSA | ALECENSARO | ALECENSA | 安圣莎盐酸阿来替尼 | ALECENSA | ALECENSA 安立適膠囊150毫克 | ||
unknown | ALECENSA | ALECENSA | ALECENSA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.